Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 21, 2014; 20(27): 9017-9025
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.9017
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.9017
Technical/scientific factors | |
Monitor/interface/biology | Too many interrelated unknowns |
Unique data: uncertain utility | Relevance difficult to establish |
Relevance may not exist | |
Non-technical factors | |
Inadequate teams | Engineers, chemists, doctors, statisticians |
Inadequate synergy | Single center efforts |
Lack of focus | Too many diseases, too little strategy |
Lack of common languages | Device development is not drug development |
Few models of commercial success | Difficult to envision endgame |
- Citation: Solga SF. Breath volatile organic compounds for the gut-fatty liver axis: Promise, peril, and path forward. World J Gastroenterol 2014; 20(27): 9017-9025
- URL: https://www.wjgnet.com/1007-9327/full/v20/i27/9017.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i27.9017